← FDA Drug Approvals (Drugs@FDA)

DOCETAXEL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2021-06-25

Drug application

FDA Application #

ANDA214575

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOCETAXEL

Generic name

DOCETAXEL

Active ingredients

DOCETAXEL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

EUGIA PHARMA

Manufacturer

Eugia US LLC

First approval

2021-06-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown